hat
"Methyltrienolone.ki se oral aktif kòm yon ajan anabolizan nan yon dòz ki mwens pase 1.0 mg chak jou nan adilt nòmal, ki te teste ak konsiderasyon enfliyans li sou fonksyon fwa. Kòm mezire pa paramèt miltip (BSP retansyon; total bilirubin; aktivite nan transaminasi, fosfat alkalin ak cholinesterase nan serom; aktivite nan proakcelerin nan plasma) methyltrienolone yo te tounen soti trè aktif kòm sa ki lakòz sentòm byochimik ki nan cholestasis entrahep. ... konsa methyltrienolone nan prezan yo te pi 'èpototoksik' esteroyid la. "
eng
“Methyltrienolone.which is orally active as an anabolic agent in a dose less than 1.0 mg per day in normal adults,has been tested with regard to its influence on liver function. As measured by multiple parameters (BSP retention; total bilirubin; activities of transaminases, alkaline phosphates and cholinesterase in serum; activity of proaccelerin in plasma) methyltrienolone turned out to be very active as to causing biochemical symptoms of intrahepatic cholestasis. …thus methyltrienolone at present being the most ‘hepatotoxic’ steroid.”